Helicon Group Shareholder Update - Jewim Pharmaceuticals Inc. China

Perth, Jan 14, 2008 (ABN Newswire) - With the regulatory process well underway in China, Helicon (ASX: HCG) has put the ReCell(R) pre-marketing program into gear with a number of activities over the last few months.